Paper1752779
Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.
Itoh Y and 9 others. Jpn J Cancer Res, 1991. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells. Papers, record 1752779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1752779
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Lung Neoplasms | Major topic |
| Lymphocytes, Tumor-Infiltrating | Major topic |
| Stomach Neoplasms | Major topic |
| Transfection | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Ascites | |
| Cell Line | |
| Humans | |
| Interleukin-2 | |
| Pleural Effusion | |
| Recombinant Proteins |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2379159 | Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor. | Cancer Res | 1990 | https://conductscience.org/library/papers/2379159 | PubMed |
| 2 | 3784109 | Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor. | Jpn J Med Sci Biol | 1986 | https://conductscience.org/library/papers/3784109 | PubMed |
| 3 | 2381442 | Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. | N Engl J Med | 1990 | https://conductscience.org/library/papers/2381442 | PubMed |
| 4 | 2793231 | Functional interactions of IL2 and TNF in the differentiation of LGL into LAK effectors. | Int J Cancer | 1989 | https://conductscience.org/library/papers/2793231 | PubMed |
| 5 | 3936830 | Antitumor effect of tumor necrosis factor against various primarily cultured human cancer cells. | Jpn J Cancer Res | 1985 | https://conductscience.org/library/papers/3936830 | PubMed |
| 6 | 2493053 | Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes. | J Immunol | 1989 | https://conductscience.org/library/papers/2493053 | PubMed |
| 7 | 3257408 | Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. | Cancer Res | 1988 | https://conductscience.org/library/papers/3257408 | PubMed |
| 8 | 3489188 | Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. | Nature | 1986 | https://conductscience.org/library/papers/3489188 | PubMed |
| 9 | 2644399 | Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. | J Clin Oncol | 1989 | https://conductscience.org/library/papers/2644399 | PubMed |
| 10 | 3486936 | Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. | J Exp Med | 1986 | https://conductscience.org/library/papers/3486936 | PubMed |
| 11 | 6170674 | Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. | J Immunol | 1981 | https://conductscience.org/library/papers/6170674 | PubMed |
| 12 | 3315281 | Phase I study of recombinant human tumor necrosis factor. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3315281 | PubMed |
| 13 | 1103152 | An endotoxin-induced serum factor that causes necrosis of tumors. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1103152 | PubMed |
| 14 | 6286831 | Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. | J Mol Appl Genet | 1982 | https://conductscience.org/library/papers/6286831 | PubMed |
| 15 | 2433337 | Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. | J Immunol | 1987 | https://conductscience.org/library/papers/2433337 | PubMed |
| 16 | 2823261 | Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2823261 | PubMed |
| 17 | 3108384 | Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells. | J Immunol | 1987 | https://conductscience.org/library/papers/3108384 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11319616 | Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule. | Gene Ther | 2001 | https://conductscience.org/library/papers/11319616 | PubMed |
| 8188531 | Augmented systemic immunity in mice implanted with tumor necrosis factor-alpha gene-transduced Meth-A-cells. | Jpn J Cancer Res | 1994 | https://conductscience.org/library/papers/8188531 | PubMed |
| 8162610 | Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8162610 | PubMed |
| 7882388 | Characterization of tumor-necrosis-factor-gene-transduced tumor-infiltrating lymphocytes from ascitic fluid of cancer patients: analysis of cytolytic activity, growth rate, adhesion molecule expression and cytokine production. | Cancer Immunol Immunother | 1995 | https://conductscience.org/library/papers/7882388 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1752779
GET https://conductscience.org/api/papers/v1/1752779/authors